Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healt ...
…
continue reading
1
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
18:41
18:41
Afspil senere
Afspil senere
Lister
Like
Liked
18:41
touchFOCUS for touchONCOLOGY Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma. The expert Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA This touchPODCAST…
…
continue reading
1
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchIMMUNOLOGY
12:49
12:49
Afspil senere
Afspil senere
Lister
Like
Liked
12:49
touchMDT for touchIMMUNOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – P…
…
continue reading
1
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchIMMUNOLOGY
14:47
14:47
Afspil senere
Afspil senere
Lister
Like
Liked
14:47
touchMDT for touchIMMUNOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ Univers…
…
continue reading
1
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchIMMUNOLOGY
15:05
15:05
Afspil senere
Afspil senere
Lister
Like
Liked
15:05
touchMDT for touchIMMUNOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The multi…
…
continue reading
1
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchDERMATOLOGY
15:04
15:04
Afspil senere
Afspil senere
Lister
Like
Liked
15:04
touchMDT for touchDERMATOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The mult…
…
continue reading
1
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchDERMATOLOGY
14:46
14:46
Afspil senere
Afspil senere
Lister
Like
Liked
14:46
touchMDT for touchDERMATOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ Univer…
…
continue reading
1
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchDERMATOLOGY
12:49
12:49
Afspil senere
Afspil senere
Lister
Like
Liked
12:49
touchMDT for touchDERMATOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – …
…
continue reading
1
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchENDOCRINOLOGY
12:49
12:49
Afspil senere
Afspil senere
Lister
Like
Liked
12:49
touchMDT for touchENDOCRINOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist …
…
continue reading
1
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchENDOCRINOLOGY
14:47
14:47
Afspil senere
Afspil senere
Lister
Like
Liked
14:47
touchMDT for touchENDOCRINOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ Univ…
…
continue reading
1
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchENDOCRINOLOGY
15:05
15:05
Afspil senere
Afspil senere
Lister
Like
Liked
15:05
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The mu…
…
continue reading
1
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease. Module 1: EGFR-mutant NSCLC:
33:56
33:56
Afspil senere
Afspil senere
Lister
Like
Liked
33:56
touchCLINICAL PERSPECTIVES for touchRESPIRATORY Listen to Dr Helena Yu outline the unmet needs and areas for research in metastatic EGFR-mutant NSCLC. Dr Antonio Passaro goes on to review the key clinical trial data in the first- and second-line settings, followed by a discussion of a patient case by Dr Helena Yu to highlight how novel agents and t…
…
continue reading
1
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease Module 1: EGFR-mutant NSCLC:
33:56
33:56
Afspil senere
Afspil senere
Lister
Like
Liked
33:56
touchCLINICAL PERSPECTIVES for touchONCOLOGY Listen to Dr Helena Yu outline the unmet needs and areas for research in metastatic EGFR-mutant NSCLC. Dr Antonio Passaro goes on to review the key clinical trial data in the first- and second-line settings, followed by a discussion of a patient case by Dr Helena Yu to highlight how novel agents and trea…
…
continue reading
1
Expanding HER2 horizons: Implications for NSCLC and beyond
41:45
41:45
Afspil senere
Afspil senere
Lister
Like
Liked
41:45
touchPANEL DISCUSSION for touchRESPIRATORY Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC. The experts Dr Razelle Kurzrock - Medical Oncologist, Medical Col…
…
continue reading
1
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
53:33
53:33
Afspil senere
Afspil senere
Lister
Like
Liked
53:33
touchCONGRESS for touchONCOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP ex…
…
continue reading
1
Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes
41:33
41:33
Afspil senere
Afspil senere
Lister
Like
Liked
41:33
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers to its uptake and how to best support patients in implementing CGM. The experts Prof. Stewart Harris, Western University, London, Ontario, Canada, Dr Anders Carlson, International Diabetes C…
…
continue reading
1
Personalizing care within the MDT for patients with early through to advanced RCC
19:36
19:36
Afspil senere
Afspil senere
Lister
Like
Liked
19:36
touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communicati…
…
continue reading
1
Selecting ART: Working with people living with HIV to find the best regimen
39:45
39:45
Afspil senere
Afspil senere
Lister
Like
Liked
39:45
touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV. The…
…
continue reading
1
Thyroid eye disease: An evolving continuum of care
38:00
38:00
Afspil senere
Afspil senere
Lister
Like
Liked
38:00
touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. The experts Dr Andrea Kossler, Stanford University School of Med…
…
continue reading
1
Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies
47:09
47:09
Afspil senere
Afspil senere
Lister
Like
Liked
47:09
touchTALKS for touchNEUROLOGY A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. The expert Prof. Dr. me…
…
continue reading
1
Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches
16:01
16:01
Afspil senere
Afspil senere
Lister
Like
Liked
16:01
touchFOCUS for touchONCOLOGY Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. T…
…
continue reading
1
The path from detection to personalized long-term care for Fabry disease
36:05
36:05
Afspil senere
Afspil senere
Lister
Like
Liked
36:05
touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham Scho…
…
continue reading
1
Demystifying virology: The link between the HIV life cycle and ART
37:54
37:54
Afspil senere
Afspil senere
Lister
Like
Liked
37:54
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV. The experts Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium Prof. José Arribas - …
…
continue reading
1
Knowledge for nurses ADC updates in breast cancer
40:21
40:21
Afspil senere
Afspil senere
Lister
Like
Liked
40:21
touchIN CONVERSATION for touchONCOLOGY Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the tre…
…
continue reading
1
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma
39:16
39:16
Afspil senere
Afspil senere
Lister
Like
Liked
39:16
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key consideratio…
…
continue reading
1
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
37:31
37:31
Afspil senere
Afspil senere
Lister
Like
Liked
37:31
touchIN CONVERSATION for touchRESPIRATORY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. The experts Prof. Enriqueta Felip - Medical Oncol…
…
continue reading
1
Early diagnosis and treatment of NMOSD: Practical insights
40:30
40:30
Afspil senere
Afspil senere
Lister
Like
Liked
40:30
touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting sympt…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 1 touchHAEMATOLOGY
14:00
14:00
Afspil senere
Afspil senere
Lister
Like
Liked
14:00
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Th…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchHAEMATOLOGY
11:34
11:34
Afspil senere
Afspil senere
Lister
Like
Liked
11:34
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA P…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchHAEMATOLOGY
13:32
13:32
Afspil senere
Afspil senere
Lister
Like
Liked
13:32
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchHAEMATOLOGY
12:01
12:01
Afspil senere
Afspil senere
Lister
Like
Liked
12:01
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, U…
…
continue reading
1
Recognizing and managing HLH in the critical care setting Best practice for the multidisciplinary team - Part 1 touchIMMUNOLOGY
14:00
14:00
Afspil senere
Afspil senere
Lister
Like
Liked
14:00
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Thi…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchIMMUNOLOGY
11:34
11:34
Afspil senere
Afspil senere
Lister
Like
Liked
11:34
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Pa…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchIMMUNOLOGY
13:32
13:32
Afspil senere
Afspil senere
Lister
Like
Liked
13:32
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist:…
…
continue reading
1
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchIMMUNOLOGY
12:01
12:01
Afspil senere
Afspil senere
Lister
Like
Liked
12:01
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, US…
…
continue reading
1
Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis
43:29
43:29
Afspil senere
Afspil senere
Lister
Like
Liked
43:29
touchIN CONVERSATION for touchNEUROLOGY Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the im…
…
continue reading
1
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
51:54
51:54
Afspil senere
Afspil senere
Lister
Like
Liked
51:54
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, Universi…
…
continue reading
1
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
51:55
51:55
Afspil senere
Afspil senere
Lister
Like
Liked
51:55
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, Univer…
…
continue reading
1
Immunotherapy for early-stage, resectable NSCLC
34:52
34:52
Afspil senere
Afspil senere
Lister
Like
Liked
34:52
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice. The expert Prof. Heather A Wakelee – Stanford University, CA, USA This touchPODCAST is for HCPs only. This activity is fund…
…
continue reading